HomeInsightsEPS

Aarti Drugs Ltd EPS

Aarti Drugs Ltd EPS

stocks purchased

₹ 0.2 Cr

Volume Transacted

(Nov 8, 2024)

stocks purchased

4.0 K

Stocks Traded

(Nov 8, 2024)

Last Updated on: Nov 08, 2024

Image

Aarti Drugs Ltd

NSE: AARTIDRUGS

EPS

₹ 16.56

Last updated on: Nov 07, 2024

Key Highlights

  • The Earning per Share of Aarti Drugs Ltd is ₹ 16.56 as of 07 Nov 24.
  • The Earning per Share of Aarti Drugs Ltd changed from ₹ 3.76 to ₹ 3.83 over 10 quarters. This represents a CAGR of 0.74% .

Historical Earning per Share of Aarti Drugs Ltd

No data available

* All values are in

Company Fundamentals for Aarti Drugs Ltd

Market Cap

4,555 Cr

EPS

16.6

P/E Ratio (TTM) *

29.9

P/B Ratio (TTM) *

3.6

Day’s High *

495.5

Day’s Low

487.3

DTE *

0.5

ROE *

11.9

52 Week High

634.9

52 Week Low

430.0

ROCE *

12.8

Market Price Over Time

1M

1Y

3Y

5Y

Monitoring Aarti Drugs Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
07 Nov 2024495.5
06 Nov 2024494.3
05 Nov 2024487.95
04 Nov 2024483.55
01 Nov 2024487.6
31 Oct 2024483.6
30 Oct 2024485.05
29 Oct 2024484.15
28 Oct 2024483.15
25 Oct 2024475.05

SWOT Analysis Of Aarti Drugs Ltd

Strength

2

S

Weakness

1

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Aarti Drugs Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Aarti Drugs Ltd

Market Value

4,555

Asset Value

1,321

2.4 X

Value addition

* All values are in Rupees

Competitive Comparison of EPS

Company NameEPSMarket Cap (INR Cr.)
Aarti Drugs Ltd164,555
Sun Pharmaceuticals Industries Ltd464,29,841
Divis Laboratories Ltd631,58,179
Cipla Ltd571,27,063
Mankind Pharma Ltd521,09,234
Dr Reddys Laboratories Ltd631,07,398

Historical Market Cap of Aarti Drugs Ltd

No data available

* All values are in crore

Historical Revenue of Aarti Drugs Ltd

No data available

* All values are in crore

Historical EBITDA of Aarti Drugs Ltd

No data available

* All values are in crore

Historical Net Profit of Aarti Drugs Ltd

No data available

* All values are in crore

Dividend Payout Over Time

No data available

Aarti Drugs Ltd News Hub

News

Aarti Drugs to conduct board meeting

Aarti Drugs will hold a meeting of the Board of Directors of the Company on 24 October 202...

Read more

18 Oct 202410:48

News

Aarti Drugs gains after arm receives UK MHRA GMP Compliance Certificate

The company said that there are no financial or material impacts as of now. With the GMP c...

Read more

04 Oct 202411:09

News

Aarti Drugs' Maharashtra facility gets 7 observations from USFDA

The API inspection was conducted from 12 September to 20 September 2024. At the conclusion...

Read more

21 Sep 202414:05

News

Aarti Drugs extends buyback offer period

Aarti Drugs announced that the bidding process of buyback offer will remain open on Monday...

Read more

16 Sep 202408:52

News

Aarti Drugs AGM scheduled

Aarti Drugs announced that the Annual General Meeting (AGM) of the company will be held on...

Read more

03 Sep 202411:38

News

Board of Aarti Drugs approves buyback of shares up to Rs 59.85 cr

The Board of Aarti Drugs at its meeting held on 26 August 2024 has approved buyback of up ...

Read more

26 Aug 202417:17

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for EPS of Aarti Drugs Ltd

What is the EPS of Aarti Drugs Ltd stock?

The Earnings Per Share (EPS) of Aarti Drugs Ltd is 16.56. An EPS is the amount of net income attributed to each share of a common stock.

How is Aarti Drugs Ltd EPS calculated?

The EPS of Aarti Drugs Ltd is calculated by dividing the net income by the number of outstanding shares. The formula is EPS = (Net Income - Dividends on Preferred Stock) / Average Outstanding Shares.

How often does Aarti Drugs Ltd report its EPS?

Aarti Drugs Ltd typically reports its EPS quarterly and annually, in conjunction with its financial statements and earnings reports.

What factors can influence Aarti Drugs Ltd EPS?

Factors that influence the EPS of Aarti Drugs Ltd include revenue changes, cost fluctuations, operational efficiency, tax rates, and one-time gains or losses.

Can Aarti Drugs Ltd EPS growth indicate future performance?

Yes, consistent growth in Aarti Drugs Ltd EPS can suggest strong financial health and effective management, potentially indicating positive future performance.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*